Taysha Gene Therapies, Inc. (TSHA) Total assets 2022–2025
Taysha Gene Therapies, Inc. (TSHA) total assets at each fiscal year-end, per SEC filings.
$343.3MFY2025 · since FY2022: $126.3M → $343.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $343.3M | +114.1% |
| FY2024 | $160.4M | -7.2% |
| FY2023 | $172.7M | +36.8% |
| FY2022 | $126.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TSHA financial trends
TSHA RevenueTSHA Net incomeTSHA Net marginTSHA Gross profitTSHA Gross marginTSHA Operating incomeTSHA Operating marginTSHA Operating cash flowTSHA Free cash flowTSHA Capital expendituresTSHA Return on equityTSHA Stock buybacksTSHA Dividends paidTSHA Total liabilitiesTSHA Shareholders’ equityTSHA overview →